The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
Open accessAbstract
Age-related increases in monoamine oxidase B (MAO-B) may contribute to neurodegeneration associated with Parkinson's disease (PD). The MAO-B inhibitor deprenyl, a long-standing antiparkinsonian therapy, is currently used clinically in concert with the dopamine precursor L-DOPA. Clinical studies suggesting that deprenyl treatment alone is not protective against PD associated mortality were targeted to symptomatic patients. However, dopamine loss is at least 60% by the time PD is symptomatically detectable, therefore lack of effect of MAO-B inhibition in these patients does not negate a role for MAO-B in pre-symptomatic dopaminergic loss. In order to directly evaluate the role of age-related elevations in astroglial MAO-B in the early initiation or progression of PD, we created genetically engineered transgenic mice in which MAO-B levels could be specifically induced within astroglia in adult animals. Elevated astrocytic MAO-B mimicking age related increase resulted in specific, selective and progressive loss of dopaminergic neurons in the substantia nigra (SN), the same subset of neurons primarily impacted in the human condition. This was accompanied by other PD-related alterations including selective decreases in mitochondrial complex I activity and increased mitochondrial oxidative stress. Along with a global astrogliosis, we observed local microglial activation within the SN. These pathologies correlated with decreased locomotor activity. Importantly, these events occurred even in the absence of the PD-inducing neurotoxin MPTP. Our data demonstrates that elevation of murine astrocytic MAO-B by itself can induce several phenotypes of PD, signifying that MAO-B could be directly involved in multiple aspects of disease neuropathology. Mechanistically this may involve increases in membrane permeant H(2)O(2) which can oxidize dopamine within dopaminergic neurons to dopaminochrome which, via interaction with mitochondrial complex I, can result in increased mitochondrial superoxide. Our inducible astrocytic MAO-B transgenic provides a novel model for exploring pathways involved in initiation and progression of several key features associated with PD pathology and for therapeutic drug testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Experiments in molecular genetics
Miller, J. H. (1972) · Medical Entomology and Zoology · Cited by 27,157
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947 · cited 1×
“has a high membrane permeability and therefore it can induce toxic effects not only within the cell of origin, but also in neighboring cells”
BackgroundHydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Trounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
Youdim, M. B. H., & Bakhle, Y. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706464 · Cited by 643
Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices
Stence, N., Waite, M., & Dailey, M. E. (2001) · Glia · doi:10.1002/1098-1136(200103)33:3<256::aid-glia1024>3.0.co;2-j · Cited by 625
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Self-citationLevitt, P., Pintar, J. E., & Breakefield, X. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.20.6385 · Cited by 526
Distinct Monoamine Oxidase A and B Populations in Primate Brain
Westlund, K. N., Denney, R. M., Kochersperger, L. M., Rose, R. M., & Abell, C. W. (1985) · Science · doi:10.1126/science.3875898 · Cited by 504
Nirenberg, M., Vaughan, R., Uhl, G., Kuhar, M., & Pickel, V. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00436.1996 · Cited by 480
Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons
Raps, S. P., Lai, J. C. K., Hertz, L., & Cooper, A. J. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)91178-5 · Cited by 417
Makar, T. K., Nedergaard, M., Preuss, A., Gelbard, A. S., Perumal, A. S., & Cooper, A. J. L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010045.x · Cited by 415
Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain
Wei Soong, N., Hinton, D. R., Cortopassi, G., & Arnheim, N. (1992) · Nature Genetics · doi:10.1038/ng1292-318 · Cited by 414
Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Maintenance of Neuronal Glutathione by Glial Cells
Sagara, J., Miura, K., & Bannai, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09802.x · Cited by 400
Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1
Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359
Westlund, K. N., Denney, R. M., Rose, R. M., & Abell, C. W. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90250-3 · Cited by 354
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
The effect of age on the activity and molecular properties of human brain monoamine oxidase
Fowler, C. J., Wiberg, �., Oreland, L., Marcusson, J., & Winblad, B. (1980) · Journal of Neural Transmission · doi:10.1007/bf01249185 · Cited by 348
Oxygen free radicals and Parkinson's disease
Adams, J. D., & Odunze, I. N. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90009-r · Cited by 289
Przedborski, S., & Vila, M. (2003) · PubMed · Cited by 286
Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
Cohen, G., Farooqui, R., & Kesler, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4890 · Cited by 286
PRZEDBORSKI, S., & VILA, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07476.x · Cited by 283
Nirenberg, M. J., Chan, J., Liu, Y., Edwards, R. H., & Pickel, V. M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04135.1996 · Cited by 240
Neuroprotective Strategies in Parkinson???s Disease: An Update on Progress
Mandel, S., Gr??nblatt, E., Riederer, P., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 237
The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.
Cohen, G. (1983) · PubMed · Cited by 226
Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons
Whittemore, E. R., Loo, D. T., & Cotman, C. W. (1994) · NeuroReport · doi:10.1097/00001756-199407000-00019 · Cited by 204
Andrews, Z. B., Horvath, B., Barnstable, C. J., Elseworth, J., Yang, L., Beal, M. F., Roth, R. H., Matthews, R. T., & Horvath, T. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4269-04.2005 · Cited by 199 · cited 1×
“superoxide indicator mitosox red via tail vein injection[38].”
Mortality in DATATOP: A Multicenter trial in early Parkinson's disease
Shoulson, & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410430309 · Cited by 165
Sugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164
Gerlach, M., Youdim, M. B. H., & Riederer, P. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.137s · Cited by 139
Kumar, M. J., Nicholls, D. G., & Andersen, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306378200 · Cited by 123
Self-citation(−)-Deprenyl, A Selective MAO-B Inhibitor, with Apoptotic and Anti-apoptotic Properties
Magyar, K. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00102-5 · Cited by 112
Riederer, P. F., Konradi, C., Schay, V., Kienzl, E., Birkmayer, G. J. D., Danielczyk, W., Sofic, E., & Youdim, M. B. H. (1987) · PubMed · Cited by 112
Dopamine-derived Dopaminochrome Promotes H2O2 Release at Mitochondrial Complex I
Zoccarato, F., Toscano, P., & Alexandre, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500657200 · Cited by 100
Irwin, I., Finnegan, K. T., DeLanney, L. E., Monte, D. A. D., & Langston, J. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90473-m · Cited by 95
Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase
Vindis, C., Séguélas, M., Lanier, S. M., Parini, A., & Cambon, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00468.x · Cited by 80
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
Damier, P., Kästner, A., Agid, Y., & Hirsch, É. C. (1996) · Neurology · doi:10.1212/wnl.46.5.1262 · Cited by 76
Oxidative Stress in a Clonal Cell Line of Neuronal Origin: Effects of Antioxidant Enzyme Modulation
Buckman, T. D., Sutphin, M. S., & Mitrovic, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03489.x · Cited by 69
Development and Characterization of a Conditional Mitochondrial Complex I Assembly System
Yadava, N., Houchens, T., Potluri, P., & Scheffler, I. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313588200 · Cited by 68
Schneider, J. S., & Denaro, F. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198807000-00006 · Cited by 59
Peng, J., Xie, L., Stevenson, F. F., Melov, S., Di Monte, D. A., & Andersen, J. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3447-06.2006 · Cited by 53
Self-citationPickel, V. M., Johnson, E., Carson, M., & Chan, J. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90105-6 · Cited by 47
A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease
Olanow, C. W. (1993) · Movement Disorders · doi:10.1002/mds.870080503 · Cited by 45
Age-related changes on MAO in B1/C57 mouse tissues: a quantitative radioautographic study
Saura, J., Richards, J. G., & Mahy, N. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9324-2_11 · Cited by 45
Budd, D. C., & Nicholls, D. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020615.x · Cited by 44
Self-citationWu, R., Murphy, D. L., & Chiueh, C. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39078.x · Cited by 43
Wei, Q., Yeung, M., Jurma, O. P., & Andersen, J. K. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961215)46:6<666::aid-jnr3>3.0.co;2-d · Cited by 33
Self-citationPeng, J., Wu, Z. J., Wu, Y., Hsu, M., Stevenson, F. F., Boonplueang, R., Roffler-Tarlov, S. K., & Andersen, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207407200 · Cited by 30
Self-citationOchs, S. D., Westfall, T. C., & Macarthur, H. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.08.010 · Cited by 28
Self-citationCloning/brain localization of mouse glutamylcysteine synthetase heavy chain mRNA
Kang, Y., Qiao, X., Jurma, O. P., Knüsel, B., & Andersen, J. K. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00049 · Cited by 23
Self-citationLeWitt, P. A. (1994) · PubMed · Cited by 20
Isolation of Monoaminergic Synaptosomes from Rat Brain by Immunomagnetophoresis
Docherty, M., Bradford, H. F., Cash, C., Ehret, M., Maître, M., & Job, T. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02053.x · Cited by 11
DATATOP-study: significance of its results in the treatment of Parkinson's disease.
Schneider, E. (1995) · PubMed · Cited by 9
Discrepant effects of culture conditions on survival and function of dopaminergic neurons
Smith, D. W., & Friedmann, T. (2004) · Neuroreport · doi:10.1097/00001756-200404290-00018 · Cited by 6
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Monoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Metadata
- Authors
- Mallajosyula, J. K., Kaur, D., Chinta, S. J., Rajagopalan, S., Rane, A., Nicholls, D. G., Di Monte, D. A., Macarthur, H., & Andersen, J. K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-02-20
- Volume
- 3
- Issue
- 2
- Pages
- e1616
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1991128766
- Cited by
- 286
- References
- 61
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.